$MGNI
Magnite Inc

2023 Q3 Form 10-Q Financial Statement

#000159597423000031 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $150.1M $152.5M $137.8M
YoY Change 2.93% 10.71% 20.29%
Cost Of Revenue $84.88M $130.2M $65.00M
YoY Change 18.29% 100.27% 28.65%
Gross Profit $65.21M $22.37M $72.78M
YoY Change -11.96% -69.27% 13.69%
Gross Profit Margin 43.45% 14.66% 52.82%
Selling, General & Admin $59.51M $70.78M $53.29M
YoY Change -15.08% 32.83% -11.56%
% of Gross Profit 91.27% 316.43% 73.22%
Research & Development $23.54M $23.38M $22.80M
YoY Change -6.35% 2.54% 25.91%
% of Gross Profit 36.1% 104.54% 31.33%
Depreciation & Amortization $39.30M $88.94M $46.16M
YoY Change -15.69% 92.68% 28.61%
% of Gross Profit 60.27% 397.62% 63.42%
Operating Expenses $83.05M $94.16M $95.39M
YoY Change -12.78% -1.29% 21.73%
Operating Profit -$17.84M -$71.80M -$22.61M
YoY Change -15.66% 217.52% -51.87%
Interest Expense -$6.100M -$8.216M -$3.154M
YoY Change 21.03% 160.49% -37.48%
% of Operating Profit
Other Income/Expense, Net -$601.0K -$1.431M $1.359M
YoY Change -83.63% -205.3% -134.79%
Pretax Income -$18.44M -$73.23M -$25.06M
YoY Change -25.71% 192.23% -50.76%
Income Tax -$1.000M $700.0K -$104.0K
% Of Pretax Income
Net Earnings -$17.48M -$73.89M -$24.95M
YoY Change -28.35% 196.1% -167.8%
Net Earnings / Revenue -11.64% -48.44% -18.11%
Basic Earnings Per Share -$0.13 -$0.54 -$0.19
Diluted Earnings Per Share -$0.13 -$0.54 -$188.4K
COMMON SHARES
Basic Shares Outstanding 137.0M shares 135.6M shares 131.9M shares
Diluted Shares Outstanding 137.4M shares 136.2M shares 132.4M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $310.5M $266.4M $233.1M
YoY Change 22.46% 14.25% 20.81%
Cash & Equivalents $310.5M $266.4M $233.1M
Short-Term Investments
Other Short-Term Assets $21.50M $22.12M $22.60M
YoY Change 0.64% -2.1% -26.06%
Inventory
Prepaid Expenses
Receivables $937.2M $908.4M $886.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.269B $1.197B $1.142B
YoY Change 17.6% 4.82% 13.73%
LONG-TERM ASSETS
Property, Plant & Equipment $46.11M $46.28M $112.1M
YoY Change 1.37% -58.71% 225.58%
Goodwill $978.2M $978.2M
YoY Change 0.0%
Intangibles $58.63M $88.39M
YoY Change -81.82%
Long-Term Investments
YoY Change
Other Assets $6.686M $7.020M $7.169M
YoY Change 9.5% -2.08% 4.0%
Total Long-Term Assets $1.176B $1.211B $1.481B
YoY Change -18.9% -18.22% -3.68%
TOTAL ASSETS
Total Short-Term Assets $1.269B $1.197B $1.142B
Total Long-Term Assets $1.176B $1.211B $1.481B
Total Assets $2.445B $2.408B $2.622B
YoY Change -3.32% -8.19% 3.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.086B $1.007B $953.5M
YoY Change 24.4% 5.57% 16.27%
Accrued Expenses $35.90M $37.25M $39.08M
YoY Change -2.47% -4.67% -0.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.600M $3.600M $3.600M
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $1.131B $1.054B $1.002B
YoY Change 23.07% 5.17% 14.71%
LONG-TERM LIABILITIES
Long-Term Debt $601.6M $635.0M $721.4M
YoY Change -16.68% -11.97% 0.38%
Other Long-Term Liabilities $1.801M $1.847M $65.97M
YoY Change 5.75% -97.2% 2211.35%
Total Long-Term Liabilities $603.4M $636.9M $787.4M
YoY Change -16.63% -19.11% 9.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.131B $1.054B $1.002B
Total Long-Term Liabilities $603.4M $636.9M $787.4M
Total Liabilities $1.793B $1.755B $1.801B
YoY Change 4.32% -2.55% 8.92%
SHAREHOLDERS EQUITY
Retained Earnings -$714.9M -$697.4M
YoY Change 46.37%
Common Stock $2.000K $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $652.1M $652.6M $821.4M
YoY Change
Total Liabilities & Shareholders Equity $2.445B $2.408B $2.622B
YoY Change -3.32% -8.19% 3.19%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$17.48M -$73.89M -$24.95M
YoY Change -28.35% 196.1% -167.8%
Depreciation, Depletion And Amortization $39.30M $88.94M $46.16M
YoY Change -15.69% 92.68% 28.61%
Cash From Operating Activities $82.10M $74.12M $42.32M
YoY Change 105.8% 75.13% 47.76%
INVESTING ACTIVITIES
Capital Expenditures $6.800M $11.07M -$5.422M
YoY Change -151.54% -304.11% -57.8%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$6.800M -$11.07M -$5.422M
YoY Change -48.46% 104.11% -99.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.70M -33.23M -7.180M
YoY Change 545.91% 362.79% -102.16%
NET CHANGE
Cash From Operating Activities 82.10M 74.12M 42.32M
Cash From Investing Activities -6.800M -11.07M -5.422M
Cash From Financing Activities -30.70M -33.23M -7.180M
Net Change In Cash 44.60M 29.82M 29.72M
YoY Change 103.22% 0.35% -110.79%
FREE CASH FLOW
Cash From Operating Activities $82.10M $74.12M $42.32M
Capital Expenditures $6.800M $11.07M -$5.422M
Free Cash Flow $75.30M $63.05M $47.74M
YoY Change 41.85% 32.06% 15.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
130175000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
65001000 usd
us-gaap Cost Of Revenue
CostOfRevenue
255003000 usd
us-gaap Cost Of Revenue
CostOfRevenue
124397000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
791298000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1486000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9046000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2141000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
1800000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19856000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
367000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-98732000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1922000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
631000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19230000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
107000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-73889000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
652578000 usd
us-gaap Net Income Loss
NetIncomeLoss
-172621000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69547000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
184734000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
92026000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
37994000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
32791000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3320000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
13976000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
39000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4649000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-701000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3269000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3397000 usd
mgni Non Cash Lease Expense
NonCashLeaseExpense
167000 usd
mgni Non Cash Lease Expense
NonCashLeaseExpense
1247000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
219000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1740000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1974000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
3039000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2696000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-48144000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-44036000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1386000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3538000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-52190000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-31927000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
765000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2370000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43223000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63952000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12734000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8653000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
5800000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
7335000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
20755000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18534000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36743000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2096000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1608000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1922000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
1800000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
74989000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
276000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
396000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15663000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9677000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9458000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2313000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23568000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
326502000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266364000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233132000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
47000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
238000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
49000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266411000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233419000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
3069000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
3308000 usd
us-gaap Interest Paid Net
InterestPaidNet
17944000 usd
us-gaap Interest Paid Net
InterestPaidNet
11423000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1382000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7164000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1092000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
695000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3277000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6590000 usd
mgni Business Combination Consideration Transferred Indemnification Claims Holdback
BusinessCombinationConsiderationTransferredIndemnificationClaimsHoldback
0 usd
mgni Business Combination Consideration Transferred Indemnification Claims Holdback
BusinessCombinationConsiderationTransferredIndemnificationClaimsHoldback
2300000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported and disclosed financial statements and accompanying footnotes. Due to the economic uncertainty of macroeconomic challenges, such as inflation, global conflict, capital market disruptions and instability of financial institutions, the risk of a recession, and other macroeconomic factors, it has become more difficult to apply certain assumptions and judgments into these estimates. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent of the impact of these factors on the Company's operational and financial performance will depend on future developments, which are highly uncertain and cannot be predicted, including but not limited to the duration and how quickly and to what extent normal economic and operating conditions can resume. During the six months ended June 30, 2023, this uncertainty continued to result in a higher level of judgment related to its estimates and assumptions. As of the date of issuance of the condensed consolidated financial statements for the three and six months ended June 30, 2023, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, judgments, or revise the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known. Actual results could differ materially from these estimates.</span></div>
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-73889000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-24954000 usd
us-gaap Net Income Loss
NetIncomeLoss
-172621000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69547000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136164000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136164000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132433000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132433000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135429000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135429000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132340000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132340000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136164000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132433000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135429000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132340000 shares
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9393000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9978000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9524000 shares
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
87000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19643000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
871000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19643000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
871000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10700000 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
152543000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137780000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
282693000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
255855000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
152543000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137780000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
152543000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
137780000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
282693000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
255855000 usd
mgni Revenue Payment Terms
RevenuePaymentTerms
P75D
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19600000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1100000 usd
CY2023Q2 mgni Accounts Payable Seller
AccountsPayableSeller
14600000 usd
CY2022Q4 mgni Accounts Payable Seller
AccountsPayableSeller
600000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1662000 usd
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2096000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1092000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3475000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
727000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
9000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
743000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
9000 usd
CY2023Q2 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
18708000 usd
CY2022Q2 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-1216000 usd
mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
19294000 usd
mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-2682000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
CY2023Q2 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
18700000 usd
mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
19300000 usd
CY2023Q2 mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
14100000 usd
mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
14600000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4600000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4600000 usd
CY2022Q2 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-1200000 usd
mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-2700000 usd
CY2022Q2 mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
-1100000 usd
mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
-2000000 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-100000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-700000 usd
CY2023Q2 mgni Accounts Payable Seller Current
AccountsPayableSellerCurrent
990823000 usd
CY2022Q4 mgni Accounts Payable Seller Current
AccountsPayableSellerCurrent
1057556000 usd
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
15731000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
19387000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15746000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15065000 usd
CY2023Q2 mgni Indemnification Claim Accrual Current
IndemnificationClaimAccrualCurrent
0 usd
CY2022Q4 mgni Indemnification Claim Accrual Current
IndemnificationClaimAccrualCurrent
2313000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1022300000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1094321000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
978200000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
978200000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
441466000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
540666000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
353074000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
287165000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
88392000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
253501000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
78700000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38800000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
165100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
77300000 usd
mgni Restructuring Impairments Settled Without Cash
RestructuringImpairmentsSettledWithoutCash
3300000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
37381000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
30134000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
14445000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6001000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
431000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
88392000 usd
CY2023Q2 mgni Restructuring Charges Merger And Acquisition Assumed Loss Contracts
RestructuringChargesMergerAndAcquisitionAssumedLossContracts
0 usd
CY2022Q2 mgni Restructuring Charges Merger And Acquisition Assumed Loss Contracts
RestructuringChargesMergerAndAcquisitionAssumedLossContracts
0 usd
mgni Restructuring Charges Merger And Acquisition Assumed Loss Contracts
RestructuringChargesMergerAndAcquisitionAssumedLossContracts
2190000 usd
mgni Restructuring Charges Merger And Acquisition Assumed Loss Contracts
RestructuringChargesMergerAndAcquisitionAssumedLossContracts
0 usd
CY2023Q2 mgni Restructuring Impairment Costs
RestructuringImpairmentCosts
0 usd
CY2022Q2 mgni Restructuring Impairment Costs
RestructuringImpairmentCosts
0 usd
mgni Restructuring Impairment Costs
RestructuringImpairmentCosts
506000 usd
mgni Restructuring Impairment Costs
RestructuringImpairmentCosts
0 usd
CY2023Q2 mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
0 usd
CY2022Q2 mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
60000 usd
mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
143000 usd
mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
2004000 usd
CY2023Q2 mgni Restructuring Impairments Settled Without Cash
RestructuringImpairmentsSettledWithoutCash
0 usd
CY2022Q2 mgni Restructuring Impairments Settled Without Cash
RestructuringImpairmentsSettledWithoutCash
0 usd
mgni Restructuring Impairments Settled Without Cash
RestructuringImpairmentsSettledWithoutCash
0 usd
mgni Restructuring Impairments Settled Without Cash
RestructuringImpairmentsSettledWithoutCash
3320000 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
142000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
917000 usd
CY2023Q2 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
0 usd
CY2022Q2 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
712000 usd
mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
7465000 usd
mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
7468000 usd
mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
7500000 usd
CY2022Q2 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
700000 usd
mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
7500000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4672000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
130000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.59
mgni Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Gross
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodGross
377000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
27000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
33.20
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4398000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.89
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y8M12D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
27656000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3581000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.54
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
25876000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1200000 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
10600000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18707000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16202000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37994000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32791000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
6700286 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
8056129 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
22768721 shares
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2100000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
6400000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
5600000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
12900000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
11100000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
200000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
400000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
900000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
700000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
400000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
700000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1700000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1200000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
1400000 usd
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
1300000 usd
us-gaap Sublease Income
SubleaseIncome
2700000 usd
us-gaap Sublease Income
SubleaseIncome
2600000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0618
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0611
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y4M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
13459000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
23336000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
15105000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12276000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7676000 usd
CY2023Q2 mgni Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
22195000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
94047000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13634000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
80413000 usd
CY2023Q2 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
31152000 usd
CY2023Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
64716000 usd
CY2023Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
31066000 usd
CY2023Q2 us-gaap Contractual Obligation
ContractualObligation
126934000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3600000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3600000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
635036000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
722757000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1800000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3600000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3600000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
313123000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3600000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
336600000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
662323000 usd
CY2023Q2 mgni Amortization Of Debt Issuance Cost And Discount
AmortizationOfDebtIssuanceCostAndDiscount
1500000 usd
mgni Amortization Of Debt Issuance Cost And Discount
AmortizationOfDebtIssuanceCostAndDiscount
3000000 usd
CY2022Q2 mgni Amortization Of Debt Issuance Cost And Discount
AmortizationOfDebtIssuanceCostAndDiscount
1600000 usd
mgni Amortization Of Debt Issuance Cost And Discount
AmortizationOfDebtIssuanceCostAndDiscount
3200000 usd
CY2023Q2 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
100000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
200000 usd
CY2022Q2 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
100000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
200000 usd
CY2021Q1 mgni Debt Instruments Capped Calls Transaction Costs
DebtInstrumentsCappedCallsTransactionCosts
39000000 usd
CY2021Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
11400000 usd
CY2021Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
27700000 usd
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001595974-23-000031-index-headers.html Edgar Link pending
0001595974-23-000031-index.html Edgar Link pending
0001595974-23-000031.txt Edgar Link pending
0001595974-23-000031-xbrl.zip Edgar Link pending
exhibit101-arequityplan.htm Edgar Link pending
exhibit102-arespp.htm Edgar Link pending
exhibit103-magnitesoframen.htm Edgar Link pending
exhibit311q22023.htm Edgar Link pending
exhibit312q22023.htm Edgar Link pending
exhibit32q22023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mgni-20230630.htm Edgar Link pending
mgni-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mgni-20230630_cal.xml Edgar Link unprocessable
mgni-20230630_def.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
mgni-20230630_pre.xml Edgar Link unprocessable
mgni-20230630_htm.xml Edgar Link completed
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mgni-20230630_lab.xml Edgar Link unprocessable